In recent days, through this medium it was reported that he Department of Health has confirmed 48 cases of Orthopox virus (mpox) in Puerto Rico so far this year and is now on alert for a new strain detected in Africa which is more transmissible, severe and deadly, which is why the call for safety and prevention to avoid new infections on the island has been reinforced.
Also, this past week, the World Health Organization (WHO) declared a public health emergency of international concern due to the intensification of cases in the Democratic Republic of the Congo and other countries in Africa.
As he usually does with his followers through social platforms, the cardiologist Dr. Juan Rivera, who is recognized in the Hispanic community and television in the United States, found the moment opportune to explain what this disease is about, which according to the Secretary of Health, Carlos Mellado, At the moment, the new strain has not been detected in Puerto Rico or the United States.
“Quick facts about monkeypox or Mpox: There are more than 17,000 cases in Africa, in 13 different countries. A little more than 500 deaths. The WHO has already definitively established that it is a global emergency. It is not a reason to panic or be afraid, but it is important to educate ourselves.”urged the doctor and also writer.
He also specified the symptoms of this disease, which constitutes a public health emergency of international importance, including: fever, muscle pain, back pain, rash that may be painful, and enlarged lymph nodes.
“How is it transmitted? From person to person, through saliva, through sexual contact… If you, for example, are in contact with sheets or some object of someone who is sick, it can also be transmitted. There is a vaccine, but there is not enough for everyone and antiviral treatment is still under investigation. This is not a reason to panic, but it is important that we are always informed,” Rivera said.
Meanwhile, according to information provided by Mellado, in Puerto Rico, surveillance systems are active and on alert to identify any imported cases from the African continent.
According to WHO, the two vaccines currently used against Mpox are recommended by the WHO Strategic Advisory Group of Experts on Immunization, and are also approved by national regulatory authorities listed by WHO, as well as by countries such as Nigeria and the Democratic Republic of the Congo.
“Last week, the Director-General launched the procedure for listing mpox vaccines for emergency use, which will accelerate access to these vaccines, especially by lower-income countries that have not yet issued their own national regulatory approval. Emergency use listing also allows partners, including Gavi and UNICEF, to procure vaccines for distribution,” the statement said.
Similarly, WHO is reportedly working with countries and vaccine manufacturers on potential vaccine donations, and is coordinating with partners through the interim medical countermeasures network to facilitate equitable access to vaccines, treatments, diagnostic tests and other tools.
